Theasaponin E1 inhibited platinum-resistant ovarian cancer cells through activating apoptosis and suppressing angiogenesis via downregulating protein expression of Jagged1-Notch1-HIF-1α axis [44]. This evidence concerns the gene HIF1A and ovarian carcinoma.